Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAWRENCE FONG

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1316901630
CMS profile
105044
Location
SEATTLE, WA

General Payments · PY2018–2024

$519,080.51

  • Reported across 101 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$19,357.14

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $11,431.74 7
Consulting Fee $7,425.00 3
Food and Beverage $500.40 4

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
F. Hoffmann-La Roche AG $11,151.23 6
ABBVIE INC. $7,580.91 7
Daiichi Sankyo Inc. $625.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $10,551.37 17
PY2019 $4,295.65 16
PY2020 $83,289.65 17
PY2021 $363,903.64 7
PY2022 $23,301.45 8
PY2023 $14,381.61 22
PY2024 $19,357.14 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $365.12 05/30/2024 Travel and Lodging Undisputed 01/23/2026 1104185674 CMS
ABBVIE INC. $45.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1103740909 CMS
ABBVIE INC. $55.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1103740911 CMS
ABBVIE INC. $6,000.00 06/25/2024 Consulting Fee Undisputed 01/23/2026 1103134459 CMS
ABBVIE INC. $123.85 06/25/2024 Travel and Lodging Undisputed 01/23/2026 1104185676 CMS
ABBVIE INC. $191.94 06/25/2024 Travel and Lodging Undisputed 01/23/2026 1104185678 CMS
ABBVIE INC. $800.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 1103134461 CMS
Daiichi Sankyo Inc. $625.00 02/28/2024 Consulting Fee Undisputed 01/23/2026 1089422297 CMS
F. Hoffmann-La Roche AG $281.46 04/22/2024 Travel and Lodging Undisputed 01/23/2026 1133052393 CMS
F. Hoffmann-La Roche AG $111.07 04/22/2024 Food and Beverage Undisputed 01/23/2026 1133052397 CMS
F. Hoffmann-La Roche AG $289.33 04/23/2024 Food and Beverage Undisputed 01/23/2026 1133052400 CMS
F. Hoffmann-La Roche AG $9,476.76 04/23/2024 Travel and Lodging Undisputed 01/23/2026 1133052405 CMS
F. Hoffmann-La Roche AG $845.34 04/23/2024 Travel and Lodging Undisputed 01/23/2026 1133052409 CMS
F. Hoffmann-La Roche AG $147.27 04/23/2024 Travel and Lodging Undisputed 01/23/2026 1133052413 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.